KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBITDA: 2009-2025

Historic EBITDA for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $386.0 million.

  • Quest Diagnostics' EBITDA rose 16.97% to $386.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 22.28%. This contributed to the annual value of $1.3 billion for FY2024, which is 6.66% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' EBITDA is $386.0 million, which was down 11.87% from $438.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' EBITDA ranged from a high of $660.0 million in Q1 2021 and a low of $135.0 million during Q4 2022.
  • In the last 3 years, Quest Diagnostics' EBITDA had a median value of $346.0 million in 2025 and averaged $343.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 277.14% in 2021, then slumped by 74.81% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' EBITDA stood at $536.0 million in 2021, then plummeted by 74.81% to $135.0 million in 2022, then soared by 97.78% to $267.0 million in 2023, then surged by 35.21% to $361.0 million in 2024, then climbed by 16.97% to $386.0 million in 2025.
  • Its last three reported values are $386.0 million in Q3 2025, $438.0 million for Q2 2025, and $346.0 million during Q1 2025.